OSI Pharmaceuticals said it agreed to buy eye disease treatment maker Eyetech Pharmaceuticals Inc. for around $935 million in cash and stock.
*For more on this story,
read the full Reuters article.
OSI Pharmaceuticals said it agreed to buy eye disease treatment maker Eyetech Pharmaceuticals Inc. for around $935 million in cash and stock.
*For more on this story,
read the full Reuters article.
Sign-up for our FREE Daily eNews update to get the latest Orange County news delivered right to your inbox!
One-Year for Only $99